Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiko Fukuda

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 1, 2006
Pharmacodynamic evaluation of tosufloxacin against Streptococcus pneumoniae in an in vitro model simulating serum concentrationYoshiko Fukuda, Masahiro Takahata, Junichi Mitsuyama
Current Eye Research|April 12, 2021
Medical Costs of and Changes in Glaucoma Treatment among Patients Newly Starting Glaucoma CareYoshiko Fukuda, Atsuki Kume, Kenji Kashiwagi
Molecular Biology Reports|July 19, 2005
Intracellular localization and domain organization of human TRIM41 proteinsMayumi Tanaka, Yoshiko Fukuda, Keisuke Mashima, et al.
Plos One|April 24, 2026
Disparity of ophthalmic surgeries in JapanTeruna Shiga, Ayane Tanaka, Yoshiko Fukuda, et al.
Neuroscience Letters|August 28, 2004
Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: a study using CRH-deficient miceYoshiko Fukuda, Kazunori Kageyama, Takeshi Nigawara, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 24, 2012
Bactericidal activity of garenoxacin against in vitro biofilm formed by nontypeable Haemophilus influenzaeMasahiro Takahata, Yoko Sugiura, Yuko Shinmura, et al.
Scientific Reports|January 25, 2026
Two year outcomes of as needed brolucizumab therapy in exudative age related macular degeneration with or without pachychoroid phenotypeYoshiko Fukuda, Yoichi Sakurada, Yumi Kotoda, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal VasculopathyYoshiko Fukuda, Yoichi Sakurada, Yumi Kotoda, et al.
Cureus|July 17, 2025
Recurrence of Intraocular Inflammation Following an Aflibercept 8-mg Injection in Eyes With a History of Intraocular Inflammation From Faricimab: A Case ReportShiori Sato, Yoichi Sakurada, Yoshiko Fukuda, et al.
International Journal of Antimicrobial Agents|November 18, 2011
In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniaeYoshiko Fukuda, Masahiro Takahata, Yoko Sugiura, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 1, 2006
Pharmacodynamic evaluation of tosufloxacin against Streptococcus pneumoniae in an in vitro model simulating serum concentrationYoshiko Fukuda, Masahiro Takahata, Junichi Mitsuyama
Current Eye Research|April 12, 2021
Medical Costs of and Changes in Glaucoma Treatment among Patients Newly Starting Glaucoma CareYoshiko Fukuda, Atsuki Kume, Kenji Kashiwagi
Molecular Biology Reports|July 19, 2005
Intracellular localization and domain organization of human TRIM41 proteinsMayumi Tanaka, Yoshiko Fukuda, Keisuke Mashima, et al.
Plos One|April 24, 2026
Disparity of ophthalmic surgeries in JapanTeruna Shiga, Ayane Tanaka, Yoshiko Fukuda, et al.
Neuroscience Letters|August 28, 2004
Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: a study using CRH-deficient miceYoshiko Fukuda, Kazunori Kageyama, Takeshi Nigawara, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 24, 2012
Bactericidal activity of garenoxacin against in vitro biofilm formed by nontypeable Haemophilus influenzaeMasahiro Takahata, Yoko Sugiura, Yuko Shinmura, et al.
Scientific Reports|January 25, 2026
Two year outcomes of as needed brolucizumab therapy in exudative age related macular degeneration with or without pachychoroid phenotypeYoshiko Fukuda, Yoichi Sakurada, Yumi Kotoda, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal VasculopathyYoshiko Fukuda, Yoichi Sakurada, Yumi Kotoda, et al.
Cureus|July 17, 2025
Recurrence of Intraocular Inflammation Following an Aflibercept 8-mg Injection in Eyes With a History of Intraocular Inflammation From Faricimab: A Case ReportShiori Sato, Yoichi Sakurada, Yoshiko Fukuda, et al.
International Journal of Antimicrobial Agents|November 18, 2011
In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniaeYoshiko Fukuda, Masahiro Takahata, Yoko Sugiura, et al.
Pageof 7